𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biologics for Inflammatory Bowel Disease: Drug Approval and Monitoring in the United States

✍ Scribed by Tremaine, William J.

Book ID
122918878
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
118 KB
Volume
35
Category
Article
ISSN
0889-8553

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapeutic drug monitoring of biologics
Therapeutic drug monitoring of biologics for inflammatory bowel disease
✍ Jean-FrΓ©dΓ©ric Colombel; Brian G. Feagan; William J. Sandborn; Gert Van Assche; A πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 434 KB πŸ‘ 1 views

## Background: Although tumor necrosis factor (tnf) antagonists are effective for the treatment of crohn's disease and ulcerative colitis, lack and loss of clinical response is a clinical challenge. accordingly, the use of therapeutic drug monitoring has been proposed as a means to optimize treatme

Hospitalizations for inflammatory bowel
Hospitalizations for inflammatory bowel disease: Profile of the uninsured in the United States
✍ Geoffrey C. Nguyen; Justina Sam; Sanjay K. Murthy; Gilaad G. Kaplan; Jill M. Tin πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

## Background: Inflammatory bowel disease (ibd) patients may be at increased risk for having no health insurance. our objectives were to assess the prevalence of hospitalized ibd patients without insurance in the us and to characterize predictive factors. ## Methods: We identified ibd admissions